Real-time enrollment status for this neuroendocrine cancer clinical trial
Current Status
Recruiting
Checked: September 2, 2026 at 7:42 PM UTC
| NCT Number | NCT07783477 |
| Recruiting Status | Recruiting |
| Condition | Neuroendocrine Cancer |
| Phase | PHASE1 |
| Target Enrollment | 16 participants |
| Active Locations | 7 sites in the US |
| Sponsor | Memorial Sloan Kettering Cancer Center |
| Last Updated on CT.gov | September 2, 2026 (19 hours ago) |
As of September 2, 2026: Clinical trial NCT07783477 is currently recruiting participants. This phase1 study for neuroendocrine cancer is actively seeking new participants at 7 locations across the United States. The study is sponsored by Memorial Sloan Kettering Cancer Center. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07783477 is actively recruiting participants as of September 2, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 7 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07783477 was last updated 19 hours ago (September 2, 2026). HelloStudys verifies this status automatically.